• 1
    World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington (DC): AIRC; 2007.
  • 2
    Chung M, Balk E, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos T. Vitamin D and calcium: systematic review of health outcomes: evidence report/technology assessment No. 183. Rockville (MD): Agency for Healthcare Research and Quality; 2009.
  • 3
    Skinner HG, Schwartz GG. Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 2008; 17(9): 23025.
  • 4
    Skinner HG, Schwartz GG. A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18(2): 5758.
  • 5
    Balesaria S, Sangha S, Walters JR. Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption. Am J Physiol Gastrointest Liver Physiol. 2009; 297(6): G11937.
  • 6
    Bouillon R, Verstuyf A, Verlinden L, Eelen G, Mathieu C. Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Rec Results Cancer Res. 2003; 164: 3536.
  • 7
    Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, Inoue Y, Morita K, Pike JW, Takeda E. The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res. 1999; 14(2): 2407.
  • 8
    Jehan F, d'Alesio A, Garabedian M. Exons and functional regions of the human vitamin D receptor gene around and within the main 1a promoter are well conserved among mammals. J Steroid Biochem Mol Biol. 2007; 103(3–5): 3617.
  • 9
    Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA. 1998; 95(18): 1052934.
  • 10
    Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res. 2001; 16(7): 125664.
  • 11
    Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008; 358(22): 235565.
  • 12
    American Cancer Society. Cancer Facts and Figures; 2010.
  • 13
    Surveillance Epidemiology and End Results 2003–2007. Bethesda (MD): National Cancer Institute US National Institutes of Health.
  • 14
    Schwartz GG, John EM, Rowland G, Ingles SA. Prostate cancer in African–American men and polymorphism in the calcium-sensing receptor. Cancer Biol Ther. 2010; 9(12): 9949.
  • 15
    Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM. Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst. 1997; 89(15): 11106.
  • 16
    Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986; 124(3): 45369.
  • 17
    Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB, Institute of Medicine. 1997 Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington (DC): National Academy Press; 1997.
  • 18
    Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005; 97(23): 176877.
  • 19
    Tseng M, Breslow RA, Graubard BI, Ziegler RG. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr. 2005; 81(5): 114754.
  • 20
    Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA, Strange RC. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen. 2004; 43(2): 1217.
  • 21
    John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res. 2005; 65(12): 54709.
  • 22
    Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Hollis BW, Giovannucci E. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate. 2007; 67(9): 91123.
  • 23
    Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, Baron AE, Lucia MS, Thompson IM, Leach RJ. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. Clin Cancer Res. 2008; 14(10): 32239.
  • 24
    Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011; 51: 31136.
  • 25
    Herawi M, De Marzo AM, Kristiansen G, Epstein JI. Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. Hum Pathol. 2007; 38(1): 728.
  • 26
    Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, Brown EM, Ratan RR. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun. 1998; 249(2): 32531.
  • 27
    Lallet-Daher H, Roudbaraki M, Bavencoffe A, Mariot P, Gackiere F, Bidaux G, Urbain R, Gosset P, Delcourt P, Fleurisse L, Slomianny C, Dewailly E, Mauroy B, Bonnal JL, Skryma R, Prevarskaya N. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene. 2009; 28(15): 1792806.
  • 28
    Jorde R, Sundsfjord J, Bonaa KH. Determinants of serum calcium in men and women. The Tromsø Study. Eur J Epidemiol. 2001; 17(12): 111723.
  • 29
    Pettifor JM, Ross P, Moodley G, Shuenyane E. The effect of dietary calcium supplementation on serum calcium, phosphorus, and alkaline phosphatase concentrations in a rural black population. Am J Clin Nutr. 1981; 34(10): 218791.
  • 30
    Reginster JY, Denis D, Bartsch V, Deroisy R, Zegels B, Franchimont P. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int. 1993; 3(5): 2715.
  • 31
    Bronner F, Slepchenko B, Wood RJ, Pansu D. The role of passive transport in calcium absorption. J Nutr. 2003; 133(5): 1426 author reply 1427.
  • 32
    Butler LM, Wong AS, Koh WP, Wang R, Yuan JM, Yu MC. Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res. 2010; 70(12): 49418.
  • 33
    Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial. 2005; 18(4): 27689.
  • 34
    Giovannucci E, Liu Y, Stampfer MJ, Willett WC. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15(2): 20310.
  • 35
    Tseng M, Giri V, Watkins-Bruner D, Giovannucci E. Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer. Cancer Causes Control. 2009; 20(10): 194754.
  • 36
    Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000; 11(9): 84752.
  • 37
    Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer. 2004; 108(1): 1048.
  • 38
    Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis. Cancer Causes Control. 2011; 22(3): 31940.
  • 39
    Schwartz G. Sunlight, Vitamin D and Prostate Cancer Epidemiology. In: Feldman D, ed. Vitamin D. 3rd edition. New York (NY): Elsevier; 2011. p. 96578.
  • 40
    Hapmap (Hapmap data release 28 phase II+III August 10 on NCBI B36 assembly dbSNP b126).
  • 41
    Fraser DR. Exploration of possible mechanisms linking vitamin D status and dietary calcium to prostate cancer. Br J Nutr. 2007; 97(4): 5967.
  • 42
    Schwartz GG. Is serum calcium a biomarker of fatal prostate cancer?. Future Oncol. 2009; 5(5): 57780.